8-K
filed November 15, 2024, 6:59 PM ET
CIK 0001267813
leadership
confidence high
sentiment negative
materiality 0.60
Three directors resign from Marinus board; board size reduced to six
MARINUS PHARMACEUTICALS, INC.
- Charles Austin, Dr. Nochur, and Dr. Noonberg resigned effective Nov 14, 2024; resignations not due to any disagreement with the Company.
- Board authorized size decreased from nine to six directors immediately following resignations.
- No replacements named; three vacancies remain on the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sarah Noonberg resigned as Director at MARINUS PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Austin resigned as Director at MARINUS PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Saraswathy V. Nochur resigned as Director at MARINUS PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.